Literature DB >> 1457270

Perturbation of paracetamol urinary metabolic ratios by urine flow rate.

J O Miners1, N J Osborne, A L Tonkin, D J Birkett.   

Abstract

The effects of high and low urine flow rates on the urinary metabolic ratios for paracetamol glucuronidation, sulphation and oxidation were determined at steady-state in seven healthy young adult volunteers. Metabolic partial clearances were unaffected by urine flow rate, but individual paracetamol metabolic ratios varied 2.5- to 3.2-fold over a 7.4-fold range of urine flow rates (0.81-6.00 ml min-1). The change in metabolic ratios was due entirely to a 2.5-fold change in renal clearance of unchanged paracetamol. These data emphasise the limitations of the metabolic ratio as a measure of intrinsic clearance for compounds which undergo some degree of tubular reabsorption.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457270      PMCID: PMC1381420          DOI: 10.1111/j.1365-2125.1992.tb05643.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.

Authors:  M E Veronese; J O Miners; D Randles; D Gregov; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1990-03       Impact factor: 6.875

2.  Plasma bombesin concentrations in patients with extensive small cell carcinoma of the lung.

Authors:  C B Pert; U K Schumacher
Journal:  Lancet       Date:  1982-02-27       Impact factor: 79.321

3.  Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events.

Authors:  D J Birkett; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

5.  Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.

Authors:  K W Bock; J Wiltfang; R Blume; D Ullrich; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese.

Authors:  N J Osborne; A L Tonkin; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

7.  Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.

Authors:  A Küpfer; R Preisig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.

Authors:  L F Prescott; G C Speirs; J A Critchley; R M Temple; R J Winney
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

Review 10.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

View more
  5 in total

Review 1.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

Review 2.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

3.  A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.

Authors:  Dan Gu; Lynn McNaughton; David Lemaster; Brian G Lake; Nigel J Gooderham; Fred F Kadlubar; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

4.  Paracetamol and metabolite pharmacokinetics in infants.

Authors:  Caroline D van der Marel; Brian J Anderson; Richard A van Lingen; Nicholas H G Holford; Marien A L Pluim; Frank G A Jansman; John N van den Anker; Dick Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2003-05-22       Impact factor: 2.953

Review 5.  Paracetamol: a focus for the general pediatrician.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Egidio Barbi
Journal:  Eur J Pediatr       Date:  2013-12-28       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.